Regulation of Private Hospital Pricing Under Article 21: Supreme Court's Directive

Introduction

The Supreme Court of India recently addressed a significant issue concerning the pricing practices of private hospitals in the case of Siddharth Dalmia & Anr. versus Union of India & Ors. The petitioners sought to restrain private hospitals from compelling patients to purchase medicines and medical devices exclusively from their pharmacies, which allegedly charge exorbitant rates compared to market prices. This judgment not only highlights the right to health as an essential component of the right to life under Article 21 of the Constitution but also emphasizes the need for regulatory measures to protect patients from exploitation.

Case Background

The writ petition was filed under Article 32 of the Constitution, purportedly in public interest, by Siddharth Dalmia and another petitioner. The case arose from the personal experience of the petitioners, whose mother was diagnosed with breast cancer and underwent extensive treatment. During this process, they became aware of the practices of private hospitals that allegedly forced patients to buy medicines from their pharmacies at inflated prices. The petitioners contended that this practice constituted exploitation and sought intervention from the Court to prevent such compulsion.

The petitioners argued that the Union of India and the States had failed to implement necessary regulatory measures to protect patients from being charged exorbitant prices for medicines and medical devices. They claimed that private hospitals often do not disclose the prices of these items, leaving patients with no choice but to purchase them at inflated rates. The petitioners sought a direction to the private hospitals to allow patients the freedom to purchase medicines from any pharmacy of their choice and urged the government to formulate policies to prevent such exploitation.

What The Lower Authorities Held

In response to the writ petition, the Union of India and various State Governments filed counter-affidavits. The Union of India highlighted that the National Council for Clinical Establishments had issued minimum standards for hospitals, including pharmaceutical services, ensuring the availability of drugs and consumables. They asserted that there was no compulsion for patients to buy medicines from the hospital's pharmacy. The States pointed out the existence of Jan Aushadhi Kendras and Amrit Drug Stores in government hospitals, which provide medicines at subsidized rates. They also referred to the Drug Price Control Order, 2013, which regulates the prices of essential drugs to ensure their availability at reasonable rates.

The States further emphasized that they had implemented various schemes to ensure affordable healthcare, including cashless treatment schemes for economically disadvantaged groups. They questioned the locus standi of the petitioners, arguing that sufficient measures were already in place to protect patients from exploitation.

The Court's Reasoning

The Supreme Court, led by Justice Surya Kant, examined the issues raised in the petition, focusing on whether the pricing practices of private hospitals could be regulated through administrative or legislative measures. The Court recognized that the provision of medical facilities is a fundamental aspect of the right to life guaranteed under Article 21 of the Constitution. It acknowledged the role of private hospitals in providing essential healthcare services, especially in light of the inadequacies in public healthcare infrastructure.

The Court deliberated on the implications of imposing strict regulations on private hospitals. It raised concerns about whether such regulations might deter investment in the healthcare sector, which is crucial for improving medical facilities across the country. The Court emphasized the need for a balanced approach that protects patients from exploitation while encouraging private entities to invest in healthcare.

The Court noted that public health and sanitation fall under the State List, indicating that any regulatory measures must be tailored to local conditions and implemented by State Governments. It concluded that while it may not be prudent to issue mandatory directions that could hinder the growth of private hospitals, it was essential to sensitize State Governments to the issue of unreasonable charges and patient exploitation.

Statutory Interpretation

The Court's ruling involved an interpretation of various constitutional provisions, particularly Article 21, which guarantees the right to life and personal liberty. The Court underscored that the right to health is an integral part of this fundamental right. Additionally, the Court referenced the Directive Principles of State Policy, particularly Articles 38, 39, and 47, which obligate the State to ensure the welfare of its citizens, including access to healthcare.

Constitutional or Policy Context

The judgment reflects a broader constitutional mandate for the State to ensure the health and well-being of its citizens. The Court's emphasis on the need for regulatory measures aligns with the constitutional vision of providing adequate healthcare facilities to all, particularly in light of the challenges posed by the private healthcare sector. The Court's directive to the State Governments to consider appropriate policy decisions underscores the importance of a collaborative approach to healthcare regulation.

Why This Judgment Matters

This ruling is significant for several reasons. Firstly, it reinforces the right to health as a fundamental aspect of the right to life, compelling the State to take proactive measures to protect patients from exploitation in the healthcare sector. Secondly, it highlights the need for a regulatory framework that balances the interests of private healthcare providers with the rights of patients. The Court's directive to the State Governments to formulate policies to address pricing issues in private hospitals is a crucial step towards ensuring fair access to healthcare.

Final Outcome

The Supreme Court disposed of the writ petition with a direction to all State Governments to consider the issues raised and take appropriate policy decisions. The Court clarified that it had not expressed any opinion on the merits of the case but had highlighted the plight of patients and the need for regulatory measures to address their grievances.

Case Details

• Case Title: Siddharth Dalmia & Anr. Versus Union of India & Ors.
• Citation: 2025 INSC 351
• Court: IN THE SUPREME COURT OF INDIA
• Bench: Justice Surya Kant, Justice Nongmeikapam Kotiswar Singh
• Date of Judgment: 2025-03-04